Back to companies
NeuroSense Therapeutics Ltd.
NRSNILNASDAQPharmaceuticals & HealthcareNeuroSense Therapeutics Ltd.
Revenue
—
FY2025
Operating income
-$11.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API